Kite Receives U.S. FDA Approval of Viral Vector Manufacturing Facility in Southern California to Produce Commercial Product Pharmaceutical Investing
SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY Pharmaceutical Investing
Cardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac Fibrosis Pharmaceutical Investing
AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022 Pharmaceutical Investing
Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27 Life Science Investing
BriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7th Pharmaceutical Investing
Cardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of America Pharmaceutical Investing
Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations Pharmaceutical Investing
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company Pharmaceutical Investing
BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives Pharmaceutical Investing
XEN® 63 Gel Implant available now for patients with primary open angle glaucoma where previous medical treatments have failed Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
